Tesla faces downside risk toward $310 unless it breaks above $351.
2 extracted signals · 2 resolved · 0 still active
Wicked Stocks29 Aug 2025, 16:33 UTC
AI-generated source summary
The analysis focuses on TSLA and NVDA. For TSLA, immediate downside targets are identified at $329.94 within 3-5 days and $310.74 within 2-3 weeks. A break below $339.81 today would signal a Monday test of $329.94. Failure to hold above $351.81 keeps $310.74 in reach. Profit-taking is advised at $310.74, with a consideration to reverse to a long position targeting the $350s again within 2-3 weeks. A settlement below $310.55 would signal a 3-5 week sell-off towards $261.49. For NVDA closing above $182.70 is a buy signal targeting 219.64 by end of the year. Closing above $182.39 may signal the beginning of a rally. A close below $168.79 is a sell signal targeting $149.29.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from Wicked Stocks
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 31st, 2026
#TSLA MAY BOUNCE FIRST... THEN FALL TO $227 #Tesla #daytrading
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 30th, 2026
#TSLA BOUNCED FROM $300... BUT IS IT A TRAP? #Tesla #daytrading
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 29th, 2026
#TSLA $300 TEST IS ALMOST HERE #Tesla #daytrading
Wicked Stocks
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

